Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. The
Uncategorized
Weight regain seems to occur within 2 years of stopping obesity drugs
Weight-loss drugs like Mounjaro (tirzepatide) are very effective – so long as you actually take them Allan Swart / Alamy People who stop taking
Investing Legend Warren Buffett Made This Surprising Buy Before Retiring. Is This Stock Right for You?
Buffett directed Berkshire Hathaway’s investing through the last quarter of 2025. Warren Buffett has held the spotlight on the investing stage for 60 years.
5 Key Signs You’re Letting Fear Hold You Back From Investing Wisely
John Schmoll January 7, 2026 at 4:55 PM Liubomyr Vorona / Getty Images Investing in the stock market is a key part of building
This weight loss option beats Ozempic by 5 times
A new real-world comparison finds that bariatric surgery leads to dramatically more weight loss than popular injectable medications. After two years, people who underwent
What Are Research Reports? Creation and Impact in Investing
Key Takeaways A research report is a detailed document prepared by analysts or strategists, typically from brokerage firms or investment banks, offering investment analysis.
14 Most Buzzing Stocks to Invest In According to Hedge Funds
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a
First-Ever Wegovy Weight Loss Pill is Now Available in the U.S.— Here’s How You Can Get It
Until recently, the popular weight loss treatment called Wegovy was only available in injection form. The newly-launched pills are cheaper than the injections. The
Goldman Sachs sees regulation driving next wave of institutional crypto adoption
Wall Street giant Goldman Sachs (GS) said improving regulation and the emergence of crypto use cases beyond trading are underpinning a constructive outlook for
FDA Approves Wegovy Weight Loss Pill: How It Compares to Injectables
Share on PinterestThe Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of